Barely Significant
← all excerpts

Analysis of integrated clinical safety data of tadalafil in patients receiving concomitant antihypertensive medications.

J Clin Hypertens (Greenwich) · 2022 · PMC8845471 · PMID 35099113

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

nominally significantp ‐value < .05actually significant
An additional analysis of the current study data suggests that, when compared to placebo with no concomitant use of AHM, tadalafil provides small nominally significant drops ( p ‐value < .05) in BP of less than 1.5 mmHg and often less than 1.0 mmHg.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.